Extremely rare pediatric brain tumors, such as astroblastoma, are among the most devastating and least understood childhood cancers. With so few cases worldwide, research struggles to meet the urgent need for better treatments. Families often face deep uncertainty when answers matter most.
Specialized research is the only way to change this reality. By uncovering how these tumors grow and respond to therapy, scientists can develop targeted treatments to reach the children who need them.
At Children’s National Hospital in Washington, D.C., a dedicated International Rare Brain Tumor Registry drives urgent progress. This global collaboration unites data on many different ultra-rare tumor types and enables experts to examine how these diseases grow and affect children. This work lays the foundation needed to create more precise treatments for children with astroblastoma, DICER1 sarcoma, and other ultra-rare tumors.
More discovery is essential to turn scientific insight into lifesaving care, and the time to act is now. Community support helps fund early-stage studies, advance new lab technologies and expand tumor sample collection to move promising science toward safer, more effective therapies for young patients.